New hope for Hard-to-Treat breast cancer? first human trial underway
Disease control
Completed
This study tested a new drug called OP-1250 in 153 adults with advanced or metastatic hormone receptor-positive, HER2-negative breast cancer. The goal was to find the safest dose and see if the drug can shrink tumors. Participants had already tried at least one hormone therapy be…
Phase: PHASE1, PHASE2 • Sponsor: Olema Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC